Tag Archives: HEA

A Comprehensive Introduction of the oneClick+ antigen platform

SHANGHAI, Oct. 22, 2024 /PRNewswire/ — Sanyou Bio provides oneClick+ antigen one-stop solution, from antigen analysis to personalized preparation, to help tumor immunotherapy research and development. oneClick+ antigen platform is designed to provide high-quality annotation-related protein sequences, including protein amino acid sequences, isoelectric points, subcellular localization, structural domains, modification sites, and other properties, and to demonstrate non-redundant datasets, which help scientists to simplify the antigen analysis process and solve antigen expression difficulties. Sanyou provides high quality protein expression products covering mammalian, insect and bacterial expression, three major high quality protein expression systems to help your protein expression research.

oneClick+ Antigen Access Address
Visit https://www.oneclick-plus.com/. Start accessing the oneClick+ platform and select “Design Antigen”, to begin a one-stop shop for your antigen information. 

Platform Highlights

  1. Simplified input operation
    The oneClick+ platform for antigen analysis only requires you to enter the Uniprot ID corresponding to the protein. If you need to place a customized order, you can also select the desired expression system, protein amount, and other notes.
  2. Output Sequence Full Visualization
    The report outputs the amino acid sequences of the corresponding proteins, and proteins with > 2000 amino acids can also be displayed completely.
  3. Simplification of output information
    The output report demonstrates the physicochemical properties of the relevant antigen, including the number of amino acids, molecular weight, isoelectric point, subcellular localization, and protein type, in addition to the antigen’s transmembrane structural domains, signal peptide and modification sites, and three-dimensional structural features, which filters out redundant information and reduces the time required to find information.
  4. Protein preparation difficulty evaluation function
    Sanyou Bio extracted the data of 56,547 proteins from Uniprot database, and analyzed the number of amino acids, cysteines and glycosylation sites at the amino acid level, and issued a protein preparation difficulty assessment, which is intended to be a reference for scientists to judge the difficulty of protein preparation. (You can click Protein preparation difficulty assessment to see the specific analysis process.)
    (Note: Due to the diversity of proteins and other multifaceted factors, the following is not a foregone conclusion and is for reference only.)
  5. Free reports to help research
    To obtain antigen information report outputs through the oneClick+ platform, you can enter your email, and we will send them to you in the form of a zip package. In addition, if you have any antigen customization needs or other questions, you can also leave your contact information and we will contact you within 24 hours.

HoneyNaps actively supplies “AI solutions” to U.S. medical institutions

  • Rapid commercialization and delivery to the U.S. after FDA approval
  • Aiming to achieve a 10% market share within three years
  • Aggressive sales and expansion of distribution network through U.S. subsidiaries

BOSTON, Oct. 7, 2024 /PRNewswire/ — HoneyNaps announced on September 9th that it has officially begun exporting by delivering its artificial intelligence sleep disorder diagnostic software “SOMNUM” to two medical institutions in the U.S.

eXplainable A.I, SOMNUM
eXplainable A.I, SOMNUM

The SOMNUM solution supplied to the U.S. is the third globally to receive approval from the U.S. Food and Drug Administration(FDA) in 2023. It is not just a system for interpreting biometric signal images, but a deep learning-based AI interpretation system capable of real-time analysis of multi-channel/temporal and large-scale biometric signals, developed using the world’s first explainable medical AI (XAI, eXplainable AI) technology.

The SOMNUM solution will be introduced into research on sleep health for seniors and the verification of sleep improvement programs. HoneyNaps has signed a licensing agreement based on annual usage fees for the software.

HoneyNaps is currently strengthening its B2B business with major companies in South Korea while simultaneously focusing on local sales through its U.S. subsidiary in Boston and its West Coast dealer channels, expecting continuous growth in export volume.

A HoneyNaps representative said, “The U.S. is the largest sleep medicine market in the world and still holds significant growth potential. As we officially enter the U.S. market, we will solidify our business strategy to achieve a 10% market share within three years.”

For further information, please contact:
HoneyNaps USA, Inc.
Christine Kwon / Managing Director
Email: sleep@honeynaps.com
Address: , 5th Fl., 361 Newbury Street, Boston, MA 02115
Website: www.honeynaps.com

Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process


Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams

LONDON, Sept. 23, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Relatable Healthcare, a technology company delivering Product Relationship Management (PRM) software to leading medtech companies to drive revenue and workflow efficiency.

Relatable™ is a Product Relationship Management (PRM) platform created for medtech manufacturers and distributors to unlock new competitive conversion capabilities that drive cost-efficient revenue growth. The platform establishes a single source of truth for all information associated with specific products and their direct competitors, populating a data management platform available to contracting, sales, marketing and technical support teams.

Within the Relatable™ platform, customers can now access comprehensive competitive intelligence from Clarivate in addition to product specifications and cross-references, inventory availability, sales collateral, EPP data, chemicals of concern, manufacturing origin, or any custom proprietary data a customer wishes to manage.  This partnership empowers Clarivate and Relatable clients to make confident strategic pricing decisions, streamline sales contracting processes, and enhance contract compliance by offering comprehensive tools and insights to manage the entire contracting cycle effectively. 

Andrew Lee, Vice President Medtech, Life Sciences & Healthcare, Clarivate, said: “At Clarivate, we are focused on expanding our market intelligence and data analytics offering in the medical device and technology sectors while providing powerful workflow solutions that turn data-driven insights into decisions and actions that accelerate growth for our clients. This new strategic partnership enables us to support the industry in getting products to patients faster.”

Joshua Emert, CEO of Relatable Healthcare, said: “At Relatable Healthcare, we are dedicated to creating intuitive software that modernizes how innovative medical device and supply companies leverage product intelligence to drive efficient revenue growth. We are excited to partner with Clarivate and its medtech customers to automate workflows across contracting, sales, marketing and product support. This will enable instant cross-referencing of competitive products in RFP responses, more frequent measurement of contract compliance and proactive discovery of conversion opportunities in the field.”

In an evolving healthcare landscape, medical device and supply companies, along with their distributors, face significant challenges in communicating their product value and offering consultative insights. They also struggle with driving adoption and analyzing market trends effectively. Cost-constrained healthcare providers rigorously evaluate purchasing decisions, comparing devices and supplies in detail. To meet this demand, medtech companies require up-to-date competitive intelligence and advanced software to analyze and communicate tailored portfolio insights for each contracting, sales and conversion opportunity.

This collaboration enables medtech companies to commercialize products and serve Integrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), health systems and independent hospitals, surgery centers and clinics, streamlining the entire revenue growth process more efficiently. Combining the deep product-level market knowledge of Clarivate with enterprise software by Relatable Healthcare equips medtech companies with the insights and tools to win new business and drive contract compliance.

About Clarivate

Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

About Relatable Healthcare

Relatable Healthcare is a technology company delivering pioneering Product Relationship Management (PRM) solutions for the medical device and supply industry. Our data management tools and automated workflows help leading MedTech organizations drive efficient revenue growth across the commercialization spectrum. For more information, please visit www.relatable.io

Media Contact:
Luna Ivkovic,
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com 

CSafe launches reusable Silverpod pallet shipper to help pharma companies save on disposal costs and hit sustainability targets

New pallet improves cost and operational efficiency while reducing environmental impact; includes real-time visibility with cloud connectivity

Key features include:

  • Made of fully reusable components and recyclable PCM (phase change material) refrigerants
  • New integrated real-time tracking device tracks GPS location, temperature, shock and tilt
  • Rental model reduces disposal costs and inconvenience, supported by CSafe’s recycle-reuse program
  • Available to pharmaceutical businesses and freight forwarders worldwide

MONROE, Ohio, July 29, 2024 /PRNewswire/ — CSafe, the provider of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, has announced the launch of a new reusable pallet shipper – the Silverpod MAX RE – with a host of updated features. The new and improved product will help pharmaceutical customers around the world save on disposal costs, meet their sustainability targets and improve logistical transparency during the shipping journey.

Silverpod MAX RE
Silverpod MAX RE

CSafe has taken its globally recognized, single-use Silverpod MAX passive pallet shipper and enhanced it for reuse to create Silverpod MAX RE – a highly durable PCM pallet shipper made entirely of reusable components. This product directly assists the industry in hitting newly-imposed and increasingly stringent sustainability targets, contributing to a more sustainable shipping industry.

New features also include a built-in TracSafe RLT data logger for tracking the location of the shipment, which integrates with CSafe Connect (CSafe’s integrated digital supply chain ecosystem). This enables customers to get real-time visibility of their shipments throughout the entire journey. It also monitors payload temperature, external ambient temperature, shock, tilt and GPS location.

The new shipper, which offers 120+ hours of qualified thermal protection, is made from durable exterior panels with extended edge and corner cap protection that can be used time and time again. It’s supplied via a rental model where CSafe fully manages the life cycle and return of the product, eliminating disposal costs and inconvenience for the customer. The product is supplied flat-packed for the most cost-effective delivery, storage and assembly.

Patrick Schafer, CSafe CEO, said: “Reusability and quality are a major focus for pharmaceutical businesses needing to meet their sustainability targets, and we want to make it as easy as possible for them. With the Silverpod MAX RE, we’ve turned one of our best-loved flagship shippers into a fully sustainable product, while maintaining the high quality and best-in-class technology that CSafe is known for.”

For more information, visit https://csafeglobal.com/bulk-air-cargo/silverpod-max-re/#tech-specs

About CSafe
CSafe offers the pharmaceutical cold chain a broad suite of thermal shipping solutions worldwide. With a “patient-first” focus, deep expertise and commitment to innovation, CSafe matches your requirements to the best solution for your needs. Offering nearly any size, duration and temperature – CSafe is at the heart of your cold chain. csafeglobal.com

Press contact
Dominic Alston, Ballou PR
dominic.alston@balloupr.com
csafe@balloupr.com

CSafe
CSafe

Australasian College of Pharmacy and MedAdvisor Solutions Launch MedAdvisor software training for the Queensland Community Pharmacy Scope of Practice Pilot


Uplifting pharmacists’ role in primary care and positioning pharmacies as essential care destinations in local communities 

CAMBERWELL, Australia, July 25, 2024 /PRNewswire/ — MedAdvisor Solutions and the Australasian College of Pharmacy today announced the launch of the MedAdvisor software training – Queensland Community Pharmacy Scope of Practice Pilot. The training, conducted by MedAdvisor Solutions trained pharmacy managers, provides pharmacists with the essential training for the Queensland (QLD) Scope of Practice Pilot ensuring pharmacists are equipped to manage the conditions and services included in the Pilot.

The software training is continuing professional development (CPD) accredited and focuses on accessing the MedAdvisor Solutions platform to manage user accounts, complete patient medication details, message clinicians, and use the Queensland Scope of Practice forms when prescribing, and setting booking availability. By participating in the Pilot pharmacists will enhance their ability to improve medication management and healthcare delivery for patients across Australia.

“We are excited to take another step forward in supporting Australian pharmacists by giving them the ability to expand their scope of practice,” said Wayne Marinoff, MedAdvisor Solutions President ANZ. “The Pilot represents a significant step towards enabling pharmacists to practise at the top of their scope. In doing so, we are moving towards a future where pharmacists operate outside the dispensary and offer more comprehensive healthcare solutions for patients all over the country, while leveraging technology to support better health outcomes.” 

MedAdvisor Solutions is the preferred software partner for the delivery of expanded scope of practice across community pharmacies in Australia, helping to integrate the pharmacist as a key stakeholder in primary patient care and positioning pharmacies as primary healthcare locations in local communities.

Today’s announcement builds upon MedAdvisor Solution’s commitment to empower pharmacies with the tools and resources needed to enhance patient care, streamline pharmacy operations, and meet the evolving healthcare needs of our communities. The company is dedicated to supporting Australian pharmacies in delivering a broader range of healthcare services and today’s training initiative is just one component of the broader efforts.

About MedAdvisor Solutions

MedAdvisor Solutions is a global leader of pharmacy-driven patient engagement solutions that provide individualized patient experiences to simplify the patient medication journey. Our solutions utilise an empathetic, data-driven approach to engagement and an innovative, patient-centric digital experience that empower the pharmacy of the future and inspire lasting behaviour change. MedAdvisor Solutions works with over 37,000 pharmacies across the US, Australia & New Zealand to deliver our solutions to help patients take their medication safely and effectively.

In Australia, MedAdvisor Solutions has connected over 3.7 million patients through more than 95% of Australian pharmacies. MedAdvisor Solutions is on track to become one of the largest players to aid in the global transformation of the pharmacy of the future through digital patient engagement solutions.

www.medadvisorsolutions.com

About Australasian College of Pharmacy

The Australasian College of Pharmacy is a leading education and training provider for the pharmacy industry. The College provides lifelong learning for pharmacy students, pharmacy assistants, interns, pharmacists, and proprietors.

https://www.acp.edu.au/

Press Contacts:

Ancila Desai
Chief Financial Officer and Company Secretary                    
corporate@medadvisorsolutions.com                     
+61 3 9095 3036

Belinda Connolly
Marketing Manager
Australasian College of Pharmacy
connollyb@qldguild.org.au

Logo – https://techent.tv/wp-content/uploads/2024/07/australasian-college-of-pharmacy-and-medadvisor-solutions-launch-medadvisor-software-training-for-the-queensland-community-pharmacy-scope-of-practice-pilot.jpg

Logo – https://techent.tv/wp-content/uploads/2024/07/australasian-college-of-pharmacy-and-medadvisor-solutions-launch-medadvisor-software-training-for-the-queensland-community-pharmacy-scope-of-practice-pilot-1.jpg

Kangsters Unveils Revolutionary Treadmills at Rollettes Experience 2024: Celebrating Innovation and Empowerment

LOS ANGELES, July 11, 2024 /PRNewswire/ — Kangsters, the pioneering South Korean adaptive tech startup, proudly announces its participation in the Rollettes Experience 2024. This renowned event, now celebrating its 11th anniversary, will be held from July 11-14 at the Sheraton Hotel in Los Angeles, CA. Known as the world’s largest event for women and girls with disabilities, the Rollettes Experience has a profound impact nationwide and stands as a beacon of empowerment and independence.

Kangsters' Wheely-X, an innovative cardio trainer designed for wheelchair users
Kangsters’ Wheely-X, an innovative cardio trainer designed for wheelchair users

This year, the Rollettes Experience will offer a dynamic array of activities, including vibrant dance classes led by renowned choreographers like Chelsie Hill, and insightful panels on health, wellness, and business. Kangsters joins this inspiring event, championing inclusivity, community, and forward-thinking solutions. Amidst the vibrant atmosphere, Kangsters will showcase its groundbreaking innovations, including the Wheely-X treadmill designed specifically for wheelchair users.

“At Kangsters, we are driven by a passion for inclusivity and accessibility,” remarked Tyrion Kim, CEO and Co-founder. “The Rollettes Experience 2024 embodies everything we stand for: innovation that empowers individuals with disabilities to lead active, fulfilling lives.”

Visitors to the Kangsters booth at Rollettes Experience 2024 can look forward to an immersive experience with cutting-edge technology. Attendees will have the opportunity to interact firsthand with Kangsters’ XR-based indoor cardio trainers, designed for wheelchair users to compete and train with friends in an exhilarating environment, and witness the revolution in accessible fitness.

For more information about Kangsters and its pioneering products, please visit [www.wheely-x.com](http://www.wheely-x.com).

Kantar BrandZ 2024 Rankings: Haier Leads for the Sixth Consecutive Year as Premier IoT Ecosystem Brand

QINGDAO, China, June 12, 2024 /PRNewswire/ — Haier, the number one brand in the household appliances sector, has once again distinguished itself as the only Internet of Things (IoT) ecosystem brand on the Kantar BrandZ Most Valuable Global Brands 2024 list, marking the sixth consecutive year it has achieved this accolade. This achievement underscores Haier’s enduring global leadership and innovation in integrating technology with user-centric solutions.

The announcement from Kantar highlights a significant trend toward deeper integration of technology with branding, an accelerated globalization of brands, along with a greater emphasis on evaluating sustainability. The total value of the top 100 global brands has surged by 20% year-on-year to $8.3 trillion, nearing the peak value recorded in 2022. Since its inception in 2006, the total brand value of these leading global entities has grown by an impressive 474%, with entry thresholds escalating from $4 billion to $19 billion, a 354% increase.

Haier Leads for the Sixth Consecutive Year as Premier IoT Ecosystem Brand
Haier Leads for the Sixth Consecutive Year as Premier IoT Ecosystem Brand

Sustained Growth and Innovation Drive Haier’s Success

Haier’s consistent rise through the ranks, from its debut at 89th place in 2019 to 58th this year, reflects the substantial growth in brand value facilitated by pioneering IoT-driven ecosystems. In the fiscal year 2023, Haier reported robust financial results with global revenues reaching RMB371.8 billion ($52.3 billion) and profits totaling RMB26.7 billion ($3.76 billion). Zhou Yunjie, Chairman and CEO of Haier Group attributes this performance to their ecosystem brand strategy which acts as a stabilizer, driver, and accelerator for high-quality corporate development.

“Haier has originated and is at the forefront of the ecosystem brand-new paradigm, dedicated to breaking new ground in original technology. By leveraging technological innovation to spur industry innovation, it guides the direction of global industry growth,” said Doreen Wang, Kantar China CEO and Global Head of BrandZ, “Haier was the first to introduce an intelligent interaction engine in the industry, enabling unlimited possibilities for enhancing life with users and for industry development with ecological partners, which has led to ongoing enhancements in brand value and rankings.”

Prioritizing Two Pillars Tracks to Boost High-quality Development in the Sector

Haier leads the way in ecosystem branding on a global scale, aiming to build lifelong customers by constantly interacting, refining experiences, with users. 

  • The company’s premium brand Casarte exemplifies how it leads through high-end innovative offerings that have seen a thirteen-fold increase over seven years, topping industry averages across price points and market share growth metrics.
  • Through the creation of COSMOPlat, an industrial internet platform created by Haier Group, representing the initiative of “big enterprises co-creating, smaller enterprises sharing”, it has developed ecosystems in 15 fields, such as chemicals, mold production, and the automotive industry. It has now engaged with more than 900,000 firms, assisted over 160,000 businesses, and has formulated a holistic digital empowerment approach that spans from businesses to industrial parks, to sectors, and ultimately to urban areas.
  • In the health sector, anchored in scientific creativity and digital intelligence, strategically focuses on life sciences, clinical medicine, and biotechnology. It provides avant-garde solutions in these sectors while partnering with more than 60 international organizations to serve multiple countries abroad, contributing to the development of an international public health ecosystem.

By securing the position as the only global IoT ecosystem brand on the Kantar BrandZ Most Valuable Global Brands 2024 list for the sixth time in a row, Haier has shown not just its ability to lead in the ecosystem brand paradigm; but also proven its resilience and consistent growth, during its 40-year long journey starting from 1984.

About Haier Group

Founded in 1984, Haier Group is a leading global provider of better life and digital transformation solutions. Based on the purpose of “More Creation, More Possibilities”, we’ve always been user centered, adhered to original technology, and built a landscape of two pillars, Smart Living and Industrial Internet. We have built 10 R&D centers and 143 manufacturing centers around the world. We are the world’s only IoT ecosystem brand that has been ranked in the Kantar BrandZ Top 100 Most Valuable Global Brands for six consecutive years, and we have held the No.1 position in Euromonitor’s Global Major Appliances Brand for 15 consecutive years.

Orion Health awarded Panda Health Partner status for its Orchestral Health Intelligence Platform

NEW YORK, May 19, 2024 /PRNewswire/ — Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform.

Panda Health connects hospitals and digital health companies, ensuring easier solution identification, selection, and procurement. Orion Health has joined a carefully selected group of digital health companies within the Panda Health ecosystem, who have passed cybersecurity, compliance, and technical evaluations and have been vetted for viability and value.

Orchestral is a health-centric data platform built on scalable and modular technologies that can be used to acquire and analyze data for individual, cohort, and population health management. It supports organizations as they progress from achieving consistent patient data to actionable predictive insights.

Orchestral provides an open, cloud-enabled, enterprise-wide extensible health data supermodel that can absorb any data attributes or standards, and store and output them in any format while balancing meeting standardized, national requirements and the flexibility to meet local variations. Health Systems can significantly improve data governance and time to deliver insights with built in machine learning, algorithm management, and a self-service analytics infrastructure that helps offload work for existing IT teams.

“Orchestral is the culmination of 30 years of Orion Health working with healthcare data and handling over 150 million patient records globally. Being a Panda Health Partner continues that journey by making a truly intelligent health data platform for the future available to more US Health Systems than ever before,” says James Henderson, SVP of North America, Orion Health.

About Orion Health 

Orion Health is a global healthcare technology company focused on reimagining healthcare for all. We are leading the change in digital health with health and care organizations to improve the well-being of every individual with our world-leading Unified Healthcare Platform. Made up of a Virtuoso digital front door, Amadeus digital care record, and Orchestral health intelligence platform – each underpinned by extensive health and social data sets, machine learning, and 30 years of innovation focused purely on improving global well-being. www.orionhealth.com

About Panda Health

Panda Health transforms how health systems connect with, explore, and adopt leading digital health technologies that improve the lives of patients and providers. Panda’s deep market intelligence and personalized guidance de-risk the digital health procurement process. Panda was founded in 2020 through a partnership between CentraCare, Gundersen Health System, ThedaCare and the development and investment firm Fitzroy Health.

VentureBlick Launches ‘Discovery’: The First Global Networking Platform for Healthcare Innovation

Empowering key ecosystem players to find each other easily and work together

SINGAPORE, May 8, 2024 /PRNewswire/ — VentureBlick announces the launch of Discovery, a groundbreaking networking platform designed to connect healthcare innovators, advisors, investors, distributors, partners, and service providers worldwide.

VentureBlick Discovery networking platform for healthcare innovation
VentureBlick Discovery networking platform for healthcare innovation

Healthcare innovation is often associated with high barriers and risks, necessitating more cross-border and cross-sector collaboration for global impact. Discovery is the first-ever platform bringing together key stakeholders in healthcare innovation under one virtual roof.

It is free to join Discovery, which is line with the platform’s mission to foster openness, enhance visibility, and facilitate connections throughout the ecosystem.

Since its soft launch a few weeks ago, Discovery has attracted close to 3,000 members from across 50 countries, underscoring its global appeal and potential for growth.

Innovators, investors, and distributors alike stand to benefit from Discovery’s comprehensive suite of tools and resources. Innovators can showcase their breakthrough technologies on a global stage, connect with potential partners and investors beyond their home market, and access essential resources for growth and expansion. Investors can identify promising investment opportunities, gain valuable market intelligence, and engage directly with industry experts. Distributors can expand their product portfolios into new territories or new geographies and forge new partnerships.

One of Discovery’s distinguishing features is its exclusive access to a carefully curated list of advisors. These advisors are either practicing clinicians or industry experts with domain expertise and an innovative mindset, chosen to be part of the global VB Advisory Network. They undergo rigorous vetting to provide innovators with invaluable real-world feedback, clinical insights, and critical resources. VentureBlick is committed to prioritising medical value when it comes to validating and supporting healthcare innovation, making the VB Advisory Network an essential component of this mission.

Advisors can leverage Discovery to stay informed about the latest innovations in their specialty areas, connect with like-minded peers and industry experts, monetise their expertise through paid consulting engagements, and explore business opportunities.

Chris Lee, Founder & CEO of VentureBlick, expressed his enthusiasm for the launch of Discovery, stating, “Discovery was created with the simple purpose of helping people within the healthcare innovation ecosystem find each other and work together instead of relying on their own professional network, which can be limited.”

Discovery offers a range of features tailored to meet the diverse needs of its members, including user profiles and filtered directories, and direct messaging capabilities. More features including Open Innovation Search, 1-to-1 expert call on-demand, smart matching, and open Q&A forum will soon be introduced, further enhancing the platform’s utility and effectiveness.

For more information about VentureBlick and Discovery, please visit www.ventureblick.com.

About VentureBlick

VentureBlick is an all-in-one healthcare innovation engine, driving connections across borders to propel local innovations onto the global stage. Its suite of services includes the Super Incubator, Consulting, and the innovative Discovery networking platform. VentureBlick fosters collaboration among innovators, clinicians, investors, and ecosystem partners worldwide. Boasting a seasoned team and a network of 2,500 healthcare experts from 60 countries, VentureBlick is committed to prioritising medical value and driving impactful open innovation. Headquartered in Singapore and operating in Korea, Germany, India, and China, VentureBlick has a track record of guiding startups, SMEs, and corporations achieve their milestones through global market mapping, medical validation, market entry strategies, technology scouting, healthcare partnership, and beyond. Discover more at www.ventureblick.com.

Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success


Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics 

LONDON, May 2, 2024 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions.

CMC activities account for nearly 18% of the entire R&D budget, emphasizing the importance of optimization and validation. Cortellis CMC Intelligence for post-approval variations enables clients to compare requirements across 64 countries, reducing tracking time and increasing submission rates with organized, timely, and accurate information.

Justin Hubbard, Vice President, Product Management, Life Sciences & Healthcare, Clarivate, said: “This enhancement underscores our commitment to simplifying the complexities of CMC regulatory dossier submissions for our clients. By offering transformative insights, Clarivate accelerates their path to markets and patients. With the ability to efficiently compare regulations across countries for small molecules and biologics, as well as automate CMC regulatory monitoring through user-configured alerts, clients can navigate the process with confidence.” 

With its new module covering both pre- and post-approval documents, Cortellis CMC Intelligence offers comprehensive lifecycle information for drugs and biologics. Serving as a single-platform solution for CMC requirements, it effectively reduces tracking time and unnecessary costs.

About Cortellis CMC Intelligence

Cortellis CMC Intelligence curates and tracks official CMC regulations and local practices for more than 135+ countries, territories and organizations for small molecules and 64 countries, territories and regions for biologics, with pre-and post-approval module coverage. Robust data is available for 25+ product and regulatory-related filters based on eCTD structure, including 6K+ source documents and over 2K links to Cortellis Regulatory Intelligence, providing access to expanded detail and in-depth summaries from experts in local regulatory practices, paired with reference source documents, to offer a complete picture. The addition of a new post-approval module now makes a comprehensive CMC solution with complete lifecycle information for drugs and biologics to increase submission rates and avoid costly delays. To learn more about Cortellis CMC Intelligence, visit here.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com 

Media Contact:
Luna Ivkovic
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com